AdaptHealth (AHCO) Income from Non-Controlling Interests (2019 - 2026)
AdaptHealth's (AHCO) quarterly Income from Non-Controlling Interests came in at $1.2 million in Q1 2026, up 3.46% year-on-year from $1.1 million in Q1 2025, and down 5.35% quarter-over-quarter from $1.2 million in Q4 2025.
AdaptHealth (AHCO) Income from Non-Controlling Interests (2019 - 2026) Analysis & Trends
AdaptHealth's Income from Non-Controlling Interests history runs 8 years deep, the most recent figure standing at $1.2 million for Q1 2026.
- On a quarterly basis, Income from Non-Controlling Interests rose 3.46% year-over-year to $1.2 million in Q1 2026; TTM through Mar 2026 was $4.8 million, a 7.49% increase from a year earlier, with the FY2025 full-year figure at $4.8 million, up 9.13% from the prior year.
- Income from Non-Controlling Interests retreated to $1.2 million in Q1 2026 per AHCO's latest filing, from $1.2 million in the prior quarter.
- Across five years, Income from Non-Controlling Interests topped out at $1.2 million in Q3 2025 and bottomed at $480000.0 in Q1 2022.
- The 5-year median for Income from Non-Controlling Interests is $1.1 million (2022), against an average of $1.1 million.
- Across the five-year window, Income from Non-Controlling Interests surged 535.06% in 2022 and retreated 12.43% in 2023, its largest moves.
- Year by year, Income from Non-Controlling Interests stood at $1.0 million in 2022, then dropped by 8.75% to $928000.0 in 2023, then gained by 22.95% to $1.1 million in 2024, then gained by 8.06% to $1.2 million in 2025, then fell by 5.35% to $1.2 million in 2026.
- Per Business Quant, the three latest AHCO Income from Non-Controlling Interests figures stand at $1.2 million (Q1 2026), $1.2 million (Q4 2025), and $1.2 million (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Inc. Minority (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 182.32 Bn | 175.02 Bn | 6.27 Bn | - |
| 2 | Stryker | 128.75 Bn | 125.88 Bn | 3.81 Bn | - |
| 3 | Medtronic | 107.83 Bn | 98.61 Bn | 6.41 Bn | 16.00 Mn |
| 4 | Boston Scientific | 67.61 Bn | 66.15 Bn | 3.61 Bn | -2.00 Mn |
| 5 | Edwards Lifesciences | 48.13 Bn | 44.45 Bn | 1.29 Bn | - |
| 6 | Dexcom | 28.26 Bn | 27.14 Bn | 750.30 Mn | - |
| 7 | GE HealthCare Technologies | 27.78 Bn | 25.50 Bn | 1.98 Bn | 22.00 Mn |
| 8 | Smith & Nephew | 26.99 Bn | 26.41 Bn | - | - |
| 9 | Koninklijke Philips | 23.92 Bn | 20.80 Bn | 2.07 Bn | -5.85 Mn |
| 10 | AdaptHealth | 1.49 Bn | 1.45 Bn | 111.50 Mn | 1.17 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 1.17 Mn |
| Dec 31, 2025 | 1.23 Mn |
| Sep 30, 2025 | 1.24 Mn |
| Jun 30, 2025 | 1.15 Mn |
| Mar 31, 2025 | 1.13 Mn |
| Dec 31, 2024 | 1.14 Mn |
| Sep 30, 2024 | 1.10 Mn |
| Jun 30, 2024 | 1.10 Mn |
| Mar 31, 2024 | 1.03 Mn |
| Dec 31, 2023 | 928,000.00 |
| Sep 30, 2023 | 1.16 Mn |
| Jun 30, 2023 | 1.06 Mn |
| Mar 31, 2023 | 968,000.00 |
| Dec 31, 2022 | 1.02 Mn |
| Sep 30, 2022 | 1.11 Mn |
| Jun 30, 2022 | 1.22 Mn |
| Mar 31, 2022 | 480,000.00 |
| Dec 31, 2021 | 529,000.00 |
| Sep 30, 2021 | 174,000.00 |
| Jun 30, 2021 | 951,000.00 |